Provided by Tiger Fintech (Singapore) Pte. Ltd.

Menlo Therapeutics Inc.

1.35
+0.0000
Volume:- -
Turnover:- -
Market Cap:226.29M
PE:-0.67
High:1.35
Open:1.35
Low:1.35
Close:1.35
Loading ...
May 11, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
May 07, 2020

Major Issues Report

[Amend] Current report, item 9.01
Apr 23, 2020

Major Issues Report

Current report, items 1.01, 7.01, 8.01, and 9.01
Apr 16, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 10, 2020

Major Issues Report

Current report, item 5.02
Apr 06, 2020

Major Issues Report

8-K - Current report
Mar 25, 2020

Major Issues Report

Current report, items 5.02, 5.05, 7.01, and 9.01
Mar 12, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 10, 2020

Major Issues Report

8-K - Current report
Mar 09, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 03, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Feb 06, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Major Issues Report

Current report, item 8.01
Jan 28, 2020

Business Combinations

Prospectuses and communications, business combinations